Exploring Opportunities to Maximize Shareholder Value

Barkby Group, a London-listed hospitality company, is diligently exploring opportunities to optimize shareholder value through its subsidiary, Cambridge Sleep Sciences (CSS). CSS is a science-based sleep technology business known for its revolutionary product, SleepEngine. In order to align its focus on the roadside real estate strategy, Barkby Group has appointed advisors to conduct a strategic review of its investment in CSS.

Although recent press reports have sparked curiosity, it is important to note that there is no guarantee of any offer or sale involving CSS or the potential value of such a deal. Chairman Charles Dickson explains that the objective behind this strategic review is to evaluate the most suitable corporate setting and structure for CSS. This process will enable CSS to unlock its full potential, while also considering the best interests of Barkby's shareholders.

Promising Future Revenue

CSS has already inked license deals which, based on the revenue they are expected to generate, support the anticipation of revenue exceeding £10 million ($12.5 million) within the next three years. These deals are set to commence generating revenue in the fourth quarter of this year.

Potential Sale Valuation

Sky News recently reported that CSS is working closely with advisors to explore a potential sale that could value the company at approximately £50 million.

Rest assured, Barkby Group is proactively strategizing and evaluating options that will undoubtedly pave the way for CSS to thrive independently and deliver exceptional results. Stay tuned for updates as this exciting journey unfolds.